Cartesian Therapeutics (RNAC) Amortizatization of Intangibles (2016 - 2026)
Cartesian Therapeutics (RNAC) has disclosed Amortizatization of Intangibles for 10 consecutive years, with $235000.0 as the latest value for Q1 2026.
- For Q1 2026, Amortizatization of Intangibles rose 27.72% year-over-year to $235000.0; the TTM value through Mar 2026 reached $829000.0, down 60.69%, while the annual FY2025 figure was $778000.0, 68.08% down from the prior year.
- Amortizatization of Intangibles hit $235000.0 in Q1 2026 for Cartesian Therapeutics, up from $215000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.2 million in Q4 2022 and bottomed at -$293000.0 in Q2 2022.
- Average Amortizatization of Intangibles over 5 years is $408812.5, with a median of $264000.0 recorded in 2022.
- Year-over-year, Amortizatization of Intangibles crashed 205.78% in 2022 and then surged 836.72% in 2023.
- Cartesian Therapeutics' Amortizatization of Intangibles stood at $1.2 million in 2022, then crashed by 60.63% to $476000.0 in 2023, then skyrocketed by 40.97% to $671000.0 in 2024, then crashed by 67.96% to $215000.0 in 2025, then rose by 9.3% to $235000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods came in at $235000.0, $215000.0, and $192000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.